A Phase 4, Open-label Treatment, Randomized, Multicenter, 2-arm, Parallel-group, Pilot Study of Adherence to Lumacaftor/Ivacaftor in CF Subjects Homozygous for the F508del-CFTR Mutation Save

Date Added
November 22nd, 2016
PRO Number
Pro00059262
Researcher
Jennifer Hucks
Keywords
Men's Health, Pulmonary, Women's Health
Summary

The purpose of this study is to evaluate the impact of smart adherence technologies for medication monitoring on lumacaftor/ivacaftor (LUM/IVA) adherence rates among subjects 16 years of age and older with CF who are homozygous for the F508del-CFTR mutation, and to collect subject and physician feedback on the use of smart adherence technology to monitor LUM/IVA adherence.

Institution
Palmetto
Recruitment Contact
Jennifer Hucks
8035455453
alisha.henderson@uscmed.sc.edu

Change_preferences

-- OR --

Create_login